European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - pramipexole dihydrochloride monohydrate - parkinson disease; restless legs syndrome - anti-parkinson drugs - pramipexole accord is indicated in adults for treatment of the signs and symptoms of idiopathic parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end-of-dose or 'on-off' fluctuations).

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sildenafil citrate - film coated tablet - 25 milligram - sildenafil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - olmesartan medoxomil ; hydrochlorothiazide ep - film coated tablet - 20/25 milligram - olmesartan medoxomil and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - olmesartan medoxomil ; hydrochlorothiazide ep - film coated tablet - 40/25 milligram - olmesartan medoxomil and diuretics

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - vardenafil hydrochloride trihydrate - film coated tablet - 5 milligram - vardenafil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - vardenafil hydrochloride trihydrate - film coated tablet - 10 milligram - vardenafil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - vardenafil hydrochloride trihydrate - film coated tablet - 20 milligram - vardenafil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sildenafil citrate - film-coated tablet - 50 milligram(s) - drugs used in erectile dysfunction; sildenafil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - sildenafil citrate - film-coated tablet - 100 milligram(s) - drugs used in erectile dysfunction; sildenafil

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: gelatin; colloidal anhydrous silica; sodium starch glycollate; tartaric acid; stearic acid; lactose; purified water; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,treatment of recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as a first-line treatment for patients with advanced metastatic malignant melanoma.